Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Rifampicin in Healthy Volunteers
Status:
Suspended
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the bactericidal activity against Mycobacterium
tuberculosis of standard and high doses of rifampicin. Pharmacokinetics (PK) and Whole blood
Bactericidal Activity (WBA) will be measured in healthy volunteers following a single dose of
rifampicin at standard dose (10mg/kg) or at high dose (20mg/kg or 30mg/kg).